VENTRICULAR ASSIST DEVICE (VAD-C) PRACTICE TEST EXAM QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A |LATEST
EXAM UPDATE 2026/2027.
Core Domains
1. VAD-C System Components and Function
2. Patient Selection and Pre-Operative Management
3. Implantation and Surgical Techniques
4. Post-Operative Care and Hemodynamic Monitoring
5. Anticoagulation and Hematologic Management
6. Device Troubleshooting and Emergency Response
7. Ethics, End-of-Life, and Quality of Life Considerations
8. Regulatory Standards and Quality Improvement
9. Patient and Caregiver Education
10. Long-Term Management and Complications
Introduction
This comprehensive practice examination is designed to rigorously assess the knowledge
and clinical reasoning skills required for the proficient management of patients with a
,Ventricular Assist Device (VAD-C). The exam covers a broad spectrum of essential
domains, from foundational device mechanics and patient selection to complex post-
operative care, anticoagulation strategies, and ethical dilemmas. Candidates will
encounter a mix of multiple-choice questions and scenario-based items that emphasize
real-world application, critical decision-making, and adherence to professional standards.
Successful completion of this assessment indicates a deep, integrated understanding of
VAD-C therapy and a readiness to provide safe, evidence-based care.
Section One: Questions 1 – 100
1. A patient is being evaluated for a VAD-C as a bridge to transplantation. Which of
the following hemodynamic parameters is the most significant indicator of right
ventricular failure post-implantation, which would be a contraindication for the
device?
A. Central Venous Pressure (CVP) of 10 mmHg
B. Mean Pulmonary Artery Pressure (mPAP) of 20 mmHg
C. Pulmonary Capillary Wedge Pressure (PCWP) of 15 mmHg
D. Right Ventricular Stroke Work Index (RVSWI) of 4 g-m/m²
,🟢 D. Right Ventricular Stroke Work Index (RVSWI) of 4 g-m/m²
🔴 RATIONALE: A low RVSWI indicates poor right ventricular function, which is a
primary contraindication for VAD implantation. The VAD increases preload to the right
ventricle; if the RV cannot handle this, it will fail. A CVP of 10, mPAP of 20, and PCWP of
15 are not absolute contraindications and can be managed.
2. During a routine device interrogation, the VAD-C displays a "Low Flow" alarm. The
systemic blood pressure is 110/70 mmHg, and the patient is asymptomatic. The first
action the clinician should take is to:
A. Increase the pump speed to augment flow.
B. Administer a fluid bolus.
C. Auscultate for a pericardial friction rub.
D. Check the patient's heart rate.
🟢 D. Check the patient's heart rate.
🔴 RATIONALE: The most common cause of transient low flow is arrhythmia. Before
adjusting the pump or administering fluids, assessing the heart rate and rhythm is
, essential. A drop in heart rate can lead to suction events, while a fast rate may cause
inadequate filling. Auscultation is important but secondary.
3. The VAD-C system's flow probe measures flow based on which physical principle?
A. Doppler shift in ultrasound frequency.
B. The transcutaneous energy transfer (TET) system.
C. The Hall effect sensor detecting changes in magnetic fields.
D. The differential pressure across the inflow cannula.
🟢 A. Doppler shift in ultrasound frequency.
🔴 RATIONALE: The flow probe on a VAD-C typically utilizes the Doppler principle to
measure the velocity of blood flow. The TET is for power transmission. Hall effect
sensors detect rotor position, not flow. Differential pressure is not the primary method
for flow measurement.
4. What is the primary mechanism of action for preventing thrombosis in a VAD-C
system?
A. The use of a textured surface on the pump housing.
B. A high rotational speed that creates a shear force.
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A |LATEST
EXAM UPDATE 2026/2027.
Core Domains
1. VAD-C System Components and Function
2. Patient Selection and Pre-Operative Management
3. Implantation and Surgical Techniques
4. Post-Operative Care and Hemodynamic Monitoring
5. Anticoagulation and Hematologic Management
6. Device Troubleshooting and Emergency Response
7. Ethics, End-of-Life, and Quality of Life Considerations
8. Regulatory Standards and Quality Improvement
9. Patient and Caregiver Education
10. Long-Term Management and Complications
Introduction
This comprehensive practice examination is designed to rigorously assess the knowledge
and clinical reasoning skills required for the proficient management of patients with a
,Ventricular Assist Device (VAD-C). The exam covers a broad spectrum of essential
domains, from foundational device mechanics and patient selection to complex post-
operative care, anticoagulation strategies, and ethical dilemmas. Candidates will
encounter a mix of multiple-choice questions and scenario-based items that emphasize
real-world application, critical decision-making, and adherence to professional standards.
Successful completion of this assessment indicates a deep, integrated understanding of
VAD-C therapy and a readiness to provide safe, evidence-based care.
Section One: Questions 1 – 100
1. A patient is being evaluated for a VAD-C as a bridge to transplantation. Which of
the following hemodynamic parameters is the most significant indicator of right
ventricular failure post-implantation, which would be a contraindication for the
device?
A. Central Venous Pressure (CVP) of 10 mmHg
B. Mean Pulmonary Artery Pressure (mPAP) of 20 mmHg
C. Pulmonary Capillary Wedge Pressure (PCWP) of 15 mmHg
D. Right Ventricular Stroke Work Index (RVSWI) of 4 g-m/m²
,🟢 D. Right Ventricular Stroke Work Index (RVSWI) of 4 g-m/m²
🔴 RATIONALE: A low RVSWI indicates poor right ventricular function, which is a
primary contraindication for VAD implantation. The VAD increases preload to the right
ventricle; if the RV cannot handle this, it will fail. A CVP of 10, mPAP of 20, and PCWP of
15 are not absolute contraindications and can be managed.
2. During a routine device interrogation, the VAD-C displays a "Low Flow" alarm. The
systemic blood pressure is 110/70 mmHg, and the patient is asymptomatic. The first
action the clinician should take is to:
A. Increase the pump speed to augment flow.
B. Administer a fluid bolus.
C. Auscultate for a pericardial friction rub.
D. Check the patient's heart rate.
🟢 D. Check the patient's heart rate.
🔴 RATIONALE: The most common cause of transient low flow is arrhythmia. Before
adjusting the pump or administering fluids, assessing the heart rate and rhythm is
, essential. A drop in heart rate can lead to suction events, while a fast rate may cause
inadequate filling. Auscultation is important but secondary.
3. The VAD-C system's flow probe measures flow based on which physical principle?
A. Doppler shift in ultrasound frequency.
B. The transcutaneous energy transfer (TET) system.
C. The Hall effect sensor detecting changes in magnetic fields.
D. The differential pressure across the inflow cannula.
🟢 A. Doppler shift in ultrasound frequency.
🔴 RATIONALE: The flow probe on a VAD-C typically utilizes the Doppler principle to
measure the velocity of blood flow. The TET is for power transmission. Hall effect
sensors detect rotor position, not flow. Differential pressure is not the primary method
for flow measurement.
4. What is the primary mechanism of action for preventing thrombosis in a VAD-C
system?
A. The use of a textured surface on the pump housing.
B. A high rotational speed that creates a shear force.
